The 5 Ps: Building Trust and Predictability in Pharmaceutical Airfreight
Product. Packaging. Pathway. Procedures. Performance. Five interconnected elements that can help the pharmaceutical supply chain move beyond promises and demonstrate reliable, lane-specific performance.
In pharmaceutical logistics, trust is essential. But how do we demonstrate that a temperature-controlled shipment will arrive safely, particularly when it passes through multiple organisations, facilities and environments?
At Airfreight Pharma 2026 in Athens, discussions involving the Cool Chain Association (CCA) explored this challenge, particularly in relation to the development and qualification of cool corridors.
One message stood out: trust cannot be based on assumptions, labels or certifications alone. It must be supported by evidence.
During the discussion on the future of cool corridors, the five Ps were highlighted as a practical way of assessing whether a particular transportation lane is suitable for a pharmaceutical product.
Rather than evaluating individual elements in isolation, the framework considers how the entire logistics process works together.
1. Product: Start with What You Are Protecting
Every pharmaceutical product has its own stability characteristics, storage requirements and tolerance to temperature exposure.
A transportation solution that works for one medicine may not be appropriate for another, even when both products share the same labelled storage range.
Understanding the product’s stability data is therefore the starting point for any lane assessment.
This includes evaluating how the product may respond to temperature excursions, the duration of potential exposure and the risks associated with different environmental conditions.
The discussions in Athens reinforced that the suitability of a cool corridor must always begin with the product itself, rather than the availability of a particular logistics service.
The question is not simply whether a corridor is temperature controlled, but whether its conditions are appropriate for the product being transported.
2. Packaging: Match Protection to the Journey
Packaging provides an important layer of protection against temperature fluctuations during transportation.
However, no packaging solution should be considered independently of the route it will travel.
Passive and active solutions have different operating characteristics, and their effectiveness depends on factors such as ambient conditions, exposure duration, handling procedures and the product’s requirements.
The Athens discussions highlighted how seasonal variations can significantly influence packaging performance.
For example, a solution designed to protect against summer heat may require reassessment when exposed to winter conditions.
Packaging selection should therefore be supported by qualification evidence that reflects the expected transportation environment, including potential delays and worst-case conditions.
Effective packaging is not simply about the technology used. It is about demonstrating that the chosen solution is suitable for the journey.
3. Pathway: Understand Every Step of the Journey
A pharmaceutical shipment does not move through a single controlled environment.
It passes through warehouses, trucks, airports, aircraft and multiple handover points, often involving different organisations.
Each transition introduces potential operational and temperature risks.
The pathway element focuses on understanding the complete journey, including infrastructure capabilities, transfer processes, airport conditions, available capacity and the responsibilities of individual partners.
During Airfreight Pharma 2026, panellists emphasised that airports and transportation lanes cannot be assumed to perform identically.
A process that works successfully at one location may not be suitable at another, where infrastructure, climate, staffing or operating procedures differ.
Even the reverse direction of an established route may require separate assessment.
This makes lane-specific qualification essential.
A reliable pathway is not defined by the route on a map, but by what actually happens to the shipment at every stage.
4. Procedures: Make Reliability Repeatable
Even with the right product knowledge, packaging and infrastructure, operational performance depends on consistent execution.
Standard operating procedures (SOPs) establish how shipments should be handled, monitored and protected throughout the journey.
But procedures must also account for what happens when operations do not go according to plan.
What happens if an aircraft is delayed? Who decides whether a shipment should continue? How quickly can cargo be retrieved from the tarmac? Who is responsible for communicating a potential temperature excursion?
These were among the practical issues raised during the discussions in Athens.
Participants highlighted the importance of clear escalation arrangements, contingency planning and personnel empowered to make timely decisions.
Training is equally critical.
Employees must understand not only what a procedure requires, but why their actions matter to product integrity.
Procedures create consistency. Trained and empowered people make those procedures effective.
5. Performance: Prove That the Process Works
The final P brings the other four together.
Performance is about demonstrating, through reliable evidence, that the transportation process consistently delivers the required outcome.
This may include lane qualification studies, temperature monitoring records, seasonal performance data, handling-time measurements, deviation histories and evidence of effective corrective actions.
Importantly, qualification should not be treated as a one-time exercise.
Infrastructure changes, seasonal conditions, operational disruptions and evolving partner capabilities can all affect a lane’s performance.
Ongoing monitoring and periodic reassessment help ensure that the original qualification remains relevant.
The Athens discussions reinforced that greater transparency around operational performance can strengthen confidence between pharmaceutical manufacturers and logistics providers.
It also provides an opportunity to identify recurring weaknesses and improve processes before they lead to product loss.
Trust is built when performance can be demonstrated, measured and continuously improved.
Five Ps, One Connected Supply Chain
The strength of the five Ps lies in their interdependence.
The right packaging cannot compensate indefinitely for an unsuitable pathway. Well-designed procedures cannot eliminate risk if staff are not adequately trained. And performance data has limited value if it is not connected to the product requirements and operating conditions it is intended to assess.
This is particularly relevant to the development of cool corridors, where multiple independent organisations must deliver a coordinated end-to-end service.
The framework also highlights why collaboration and information sharing are essential.
Manufacturers understand product stability. Packaging providers understand protective capabilities. Airlines, freight forwarders, ground handlers and transport operators understand different aspects of the physical journey.
No single stakeholder holds all the information required to assess the entire process.
Bringing that knowledge together creates a stronger foundation for risk management, operational predictability and continuous improvement.
From Qualification to Confidence
As the pharmaceutical airfreight industry explores more scalable and cost-effective temperature-controlled solutions, the need for consistent, evidence-based assessment will become increasingly important.
The five Ps offer a useful framework for structuring those conversations, helping stakeholders identify what needs to be understood, controlled and demonstrated before a lane can be considered suitable.
For the Cool Chain Association, the discussions at Airfreight Pharma 2026 reinforced the importance of bringing different parts of the supply chain together to share expertise, challenge assumptions and improve industry practices.
Because ultimately, reliable pharmaceutical logistics is not about eliminating every possible risk. It is about understanding those risks, managing them effectively and demonstrating that the process performs as intended.
And that starts with getting all five Ps right.